Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
Vigil Neuroscience Inc. (VIGL)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Irenic Capital Management Adam Katz And Andy Dodge | 0 | $0 | 0% | |
| 2. | Point72 Asia (Singapore) Steve Cohen | 0 | $0 | 0% | |
| 3. | Point72 (DIFC) Ltd Steve Cohen | 0 | $0 | 0% | |
| 4. | Ikarian Capital Neil Shahrestani | 0 | $0 | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.71 | 12,000 | $20,520.00 | 12,000 | 2024-12-19 | Filing | |
| $1.68 | 5,000 | $8,400.00 | 222,687 | 2024-12-19 | Filing | |
| $1.67 | 5,000 | $8,350.00 | 217,687 | 2024-12-18 | Filing | |
| $2.34 | 5,000 | $11,700.00 | 212,687 | 2024-12-05 | Filing | |
| $3.75 | 4,000 | $15,000.00 | 207,687 | 2023-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.00 | 300 | $4,200.00 | 4,000 | 2022-11-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 565 | $4,548 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
Hedge Fund and Insider Trading News: Steve Cohen, Ken Griffin, Starboard Value, Angelo Gordon & Co., Ancora Advisors, Smartsheet Inc (SMAR), and More
NEW YORK & CHICAGO--(BUSINESS WIRE)--Twin Brook Capital Partners (“Twin Brook” or the “Firm”), the middle market direct lending subsidiary of Angelo Gordon, today announced that it committed $...